CANNDOC Pharma Israeli Company
Canndoc is developing pharma-grade cannabis products. Over the years, Canndoc has provided more than 500,000 doses to 15,000 patients, demonstrating expertise across the value chain from research, cultivation, and processing to product development and good manufacturing practice (GMP) clinical trial pipeline initiation.
Health Tech & Life Sciences
Alternatives
No alternatives listed yet.
Suggest an Alternative
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/canndoc
External links are provided for reference and verification purposes.